MTOR and Myocardial fibrosis: This effect is reversible with PI3K/mTOR inhibitors, indicating that the PTEN-PI3K/Akt-mTOR pathway is a potential mechanism through which BMI1 exacerbates myocardial fibrosis and worsens cardiac function after myocardial infarction [107].